Press release
Enteric Disease Testing Market worth $6.26 billion by 2030, growing at a CAGR of 5.47% - Exclusive Report by 360iResearch
Enteric Disease Testing Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/enteric-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Enteric disease testing encompasses diagnostic procedures for detecting gastrointestinal (GI) tract infections and diseases, including bacterial, viral, and parasitic pathogens causing gastroenteritis, diarrhea, and food poisoning. The necessity for such testing is high as accurate diagnosis aids in managing outbreaks, timely treatment, reducing transmission, and preventing complications, particularly among vulnerable populations such as children and the elderly. Applications span clinical diagnostics in hospitals and laboratories, point-of-care (POC) testing in healthcare settings, and surveillance by public health organizations. End-users include healthcare providers, diagnostic laboratories, and public health organizations, with additional applications in food safety and environmental monitoring. Key factors driving market growth are the rising incidence of gastrointestinal diseases, advances in diagnostic technologies, expanding healthcare infrastructure in developing regions, public health initiatives for disease surveillance, and growing awareness about enteric diseases. Opportunities lie in expanding POC diagnostic tools for underserved areas, targeting emerging markets with growing healthcare infrastructures, leveraging AI and machine learning for predictive diagnostics, and developing home-based testing kits. However, challenges such as high costs, stringent regulatory requirements, limited public health infrastructure, and sample collection issues hinder market growth. Innovation and research should focus on developing multiplex testing solutions to reduce diagnostic time and costs, discovering novel biomarkers, integrating wearable devices and Internet of Things (IoT) for continuous monitoring, and analyzing the gut microbiome for personalized diagnostics and treatment approaches. The enteric disease testing market is characterized by dynamic growth driven by technological advancements and global health priorities, involving established players and innovative startups engaged in research and development to improve diagnostic accuracy, reduce costs, and expand accessibility.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/enteric-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Enteric Disease Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Consumables, Kits, and Reagents.
Based on Disease Type, market is studied across Bacterial, Parasitic, and Viral. The Bacterial is further studied across Cholera, Escherichia coli, and Salmonellosis.
Based on Diagnostic Techniques, market is studied across Immunoassays, Molecular Diagnostics, and Rapid Diagnostics. The Molecular Diagnostics is further studied across PCR and Real-time PCR. The Rapid Diagnostics is further studied across Dipsticks and Lateral Flow Assays.
Based on Testing Site, market is studied across In-Hospital, Point-of-Care, and Standalone Laboratories.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMérieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Mérieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TÜV SÜD AG.
Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Powered Insights for the Enteric Disease Testing Market
We proudly unveil ThinkMi Query, a cutting-edge AI product designed to transform how businesses interact with the Enteric Disease Testing Market. ThinkMi Query stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi Query is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Enteric Disease Testing Market. Embrace the future of market analysis with ThinkMi Query, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi Query @ https://www.360iresearch.com/library/intelligence/enteric-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=query
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Enteric Disease Testing Market, by Product
7. Enteric Disease Testing Market, by Disease Type
8. Enteric Disease Testing Market, by Diagnostic Techniques
9. Enteric Disease Testing Market, by Testing Site
10. Americas Enteric Disease Testing Market
11. Asia-Pacific Enteric Disease Testing Market
12. Europe, Middle East & Africa Enteric Disease Testing Market
13. Competitive Landscape
14. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/enteric-disease-testing?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enteric Disease Testing Market worth $6.26 billion by 2030, growing at a CAGR of 5.47% - Exclusive Report by 360iResearch here
News-ID: 3581281 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
